Peter Boström - UTU Research Portal

Peter Boström

- Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

15 of 24

Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials) (2019)
- Journal of Magnetic Resonance Imaging
Perez IM, Jambor I, Kauko T, Verho J, Ettala O, Falagario U, Merisaari H, Kiviniemi A, Taimen P, Syvänen KT, Knaapila J, Seppänen M, Rannikko A, Riikonen J, Kallajoki M, Mirtti T, Lamminen T, Saunavaara J, Pahikkala T, Boström PJ, Aronen HJ
Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization (2019)
- PLoS ONE
Jussi Toivonen, Ileana Montoya Perez, Parisa Movahedi, Harri Merisaari, Marko Pesola, Pekka Taimen, Peter J. Boström, Jonne Pohjankukka, Aida Kiviniemi, Tapio Pahikkala, Hannu J. Aronen, Ivan Jambor
Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer (2019)
- Magnetic Resonance in Medicine
Harri Merisaari, Pekka Taimen, Rakesh Shiradkar, Otto Ettala, Marko Pesola, Jani Saunavaara, Peter J. Boström, Anant Madabhushi, Hannu J. Aronen, Ivan Jambor
Reply to Joshua S. Jue and Mahmoud Alameddine's Letter to the Editor re: Juha Knaapila, Ivan Jambor, Ileana Montoya Perez, et al. Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study (2019)
- European Urology Oncology
Knaapila J, Jambor I, Falagario U, Ettala O, Syvänen KT, Boström PJ
Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4 (2019)
- European Urology
Kimmo Kettunen, Peter J. Boström, Pekka Taimen
SORLA regulates endosomal trafficking and oncogenic fitness of HER2 (2019)
- Nature Communications
Mika Pietilä, Pranshu Sahgal, Emilia Peuhu, Niklas Z. Jäntti, Ilkka Paatero, Elisa Närvä, Hussein Al-Akhrass, Johanna Lilja, Maria Georgiadou, Olav M. Andersen, Artur Padzik, Harri Sihto, Heikki Joensuu, Matias Blomqvist, Irena Saarinen, Peter. J. Boström, Pekka Taimen, Johanna Ivaska
Tournament leave-pair-out cross-validation for receiver operating characteristic analysis (2019)
- Statistical Methods in Medical Research
Montoya Perez I., Airola A., Boström P., Jambor I., Pahikkala T.
Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment (2019)
- BJU International
Nurminen P., Ettala O., Seppänen M., Taimen P., Boström P., Kaipia A.
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial (2019)
- PLoS Medicine
Ivan Jambor, Janne Verho, Otto Ettala, Juha Knaapila, Pekka Taimen, Kari T. Syvänen, Aida Kiviniemi, Esa Kähkönen, Ileana Montoya Perez, Marjo Seppänen, Antti Rannikko, Outi Oksanen, Jarno Riikonen, Sanna Mari Vimpeli, Tommi Kauko, Harri Merisaari, Markku Kallajoki, Tuomas Mirtti, Tarja Lamminen, Jani Saunavaara, Hannu J. Aronen, Peter J. Boström
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma (2018)
- European Urology Focus
Ricardo Leão, Madhur Nayan, Nahid Punjani, Michael A.S. Jewett, Kamel Fadaak, Juan Garisto, Jeremy Lewin, Eshetu G. Atenafu, Joan Sweet, Lynn Anson-Cartwright, Peter Boström, Peter Chung, Padraig Warde, Philippe L. Bedard, Aditya Bagrodia, Yuval Freifeld, Nicholas Power, Eric Winquist, Robert J. Hamilton